CN105535448B - 一种治疗儿童重症肌无力的中药组合物 - Google Patents
一种治疗儿童重症肌无力的中药组合物 Download PDFInfo
- Publication number
- CN105535448B CN105535448B CN201610129957.5A CN201610129957A CN105535448B CN 105535448 B CN105535448 B CN 105535448B CN 201610129957 A CN201610129957 A CN 201610129957A CN 105535448 B CN105535448 B CN 105535448B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- myasthenia gravis
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 206010028417 myasthenia gravis Diseases 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 15
- 241000132012 Atractylodes Species 0.000 claims abstract description 12
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 12
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 12
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 12
- 235000006533 astragalus Nutrition 0.000 claims abstract description 12
- 241000007126 Codonopsis pilosula Species 0.000 claims abstract description 11
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 241000096284 Gynochthodes officinalis Species 0.000 claims abstract description 10
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 10
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 10
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 10
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 10
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 10
- 235000011477 liquorice Nutrition 0.000 claims abstract description 10
- 241000759833 Cornus officinalis Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 6
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- 239000006187 pill Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 8
- 239000002552 dosage form Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 241001061264 Astragalus Species 0.000 claims description 6
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 6
- 240000001341 Reynoutria japonica Species 0.000 claims description 6
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000000643 oven drying Methods 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 210000004233 talus Anatomy 0.000 claims description 6
- 244000061520 Angelica archangelica Species 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 239000006188 syrup Substances 0.000 claims description 4
- 235000020357 syrup Nutrition 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 239000006186 oral dosage form Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001376 precipitating effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 10
- 229940079593 drug Drugs 0.000 description 8
- 239000002671 adjuvant Substances 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 5
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 4
- CNLSPQQMAJCIFB-UHFFFAOYSA-N benzoic acid;ethanol Chemical compound CCO.OC(=O)C1=CC=CC=C1 CNLSPQQMAJCIFB-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 235000010241 potassium sorbate Nutrition 0.000 description 4
- 239000004302 potassium sorbate Substances 0.000 description 4
- 229940069338 potassium sorbate Drugs 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000000544 cholinesterase inhibitor Substances 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000010199 sorbic acid Nutrition 0.000 description 3
- 239000004334 sorbic acid Substances 0.000 description 3
- 229940075582 sorbic acid Drugs 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 241000209020 Cornus Species 0.000 description 2
- 239000002202 Polyethylene glycol Chemical class 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000001913 cellulose Chemical class 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229960002362 neostigmine Drugs 0.000 description 2
- LULNWZDBKTWDGK-UHFFFAOYSA-M neostigmine bromide Chemical compound [Br-].CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 LULNWZDBKTWDGK-UHFFFAOYSA-M 0.000 description 2
- -1 patches Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920001223 polyethylene glycol Chemical class 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 241000906579 Actaea cimicifuga Species 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000533865 Callerya reticulata Species 0.000 description 1
- 108010009685 Cholinergic Receptors Proteins 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 241000110637 Cuscuta chinensis Species 0.000 description 1
- 206010013887 Dysarthria Diseases 0.000 description 1
- 108010010803 Gelatin Chemical class 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000157491 Morinda Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- RVOLLAQWKVFTGE-UHFFFAOYSA-N Pyridostigmine Chemical compound CN(C)C(=O)OC1=CC=C[N+](C)=C1 RVOLLAQWKVFTGE-UHFFFAOYSA-N 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000037432 Thymic tumor Diseases 0.000 description 1
- 208000000728 Thymus Neoplasms Diseases 0.000 description 1
- 102000034337 acetylcholine receptors Human genes 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000002567 electromyography Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Chemical class 0.000 description 1
- 229920000159 gelatin Chemical class 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000017524 noni Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229960002290 pyridostigmine Drugs 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 201000009377 thymus cancer Diseases 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种治疗儿童重症肌无力的中药组合物,该中药组合物由以下重量份配比的中药原料制备而成:黄芪10‑120份、党参10‑30份、白术10‑20份、柴胡5‑8份、升麻5‑8份、当归5‑10份、山萸肉5‑10份、巴戟天5‑10份、菟丝子5‑10份、山药8‑24份、制首乌6‑30份、鸡血藤5‑12份、枸杞5‑12份、甘草3‑6份、陈皮3‑6份、麦冬3‑10份。本发明的中药配伍合理,无毒副作用,加工方便,成本低廉,治疗儿童重症肌无力效果明显,适于在临床上推广使用。
Description
技术领域
本发明属于药物领域,涉及一种治疗儿童重症肌无力的中药组合物。
背景技术
重症肌无力是神经系统难治性病症之一,其病症表现为:单侧或双侧眼睑下垂、四肢软弱无力、吞咽困难和语音不清。
传统上人们使用抗胆碱酯酶药物、胸腺切除、放射治疗三种方法治疗重症肌无力,但是抗胆碱酶药物如新斯的明、吡啶斯的明等是一种暂时性、局部起效的药物,只能短暂的延缓病情的发作,长期用药会导致人体内乙酰胆碱受体破坏,病情更加严重。在医疗应用中采用抗胆碱酶药物出现严重副作用的例子也多有报道。胸腺切除、放射治疗等手术方法一方面治愈效果不理想,五年期以上的效果有待观察;另一方面采用手术方法仅能用于出现了胸腺肿瘤这种症状的重症肌无力患者,适用范围窄。近年新出现的血浆交换法则仅能用于危重重症肌无力患者,其疗效也只能维持两周左右,费用高昂,实用价值低。
中医认为,重症肌无力属于中医范畴中的痿症症状,因此针对性地采用中药治疗应具有一定效果。
发明内容
本发明的目的在于提供一种治疗儿童重症肌无力的中药组合物,本发明的中药组合物制备方法简单,疗效好,使用安全,无副作用,适合在临床上广泛应用。
为了实现上述目的,本发明采用了如下技术方案:
本发明提供了一种治疗儿童重症肌无力的中药组合物,所述中药组合物由以下重量份配比的中药原料制备而成:黄芪(Astragalus membranaceus(Fisch.)Bge.)10-120份、党参(RADIX CODONOPSIS)10-30份、白术(Atractylodes macrocephala)10-20份、柴胡(Radix Bupleuri)5-8份、升麻(RHIZOMA CIMICIFUGAE)5-8份、当归(Angelica sinensis(Oliv.)Diels.)5-10份、山萸肉(Cornus officinalis Sieb.Et Zucc.)5-10份、巴戟天(Morinda)5-10份、菟丝子(Cuscuta chinensis Lam.)5-10份、山药(Dioscorea opposita)8-24份、制首乌(cntRd oa)6-30份、鸡血藤(Millettia reticuiata Benth.)5-12份、枸杞(Fructus Lycii)5-12份、甘草(Glycyrriza Uralensis Fisch.G.Glabra L.)3-6份、陈皮(PERICARPIUM)3-6份、麦冬(Ophiopogon japonicus(Linn.f.)Ker-Gawl.)3-10份。
进一步,所述中药组合物由以下重量份配比的中药原料配制而成:黄芪60份、党参20份、白术15份、柴胡6份、升麻6份、当归7份、山萸肉7份、巴戟天7份、菟丝子7份、山药16份、制首乌18份、鸡血藤8份、枸杞8份、甘草5份、陈皮4份、麦冬6份。
本发明提供了一种治疗儿童重症肌无力的药物制剂,所述药物制剂包括前面所述的中药组合物。
进一步,所述药物制剂的剂型是药剂学上的常规剂型。所述剂型包括但不限于,片剂、胶囊剂、丸剂、颗粒剂、混悬剂、散剂、滴丸剂、口服液、注射液、输液、冻干粉针剂、软膏剂、凝胶剂、贴剂、栓剂等。优选的剂型是口服剂型,例如片剂、胶囊剂、丸剂、颗粒剂、糖浆剂、合剂等。
进一步,所述药物制剂还包括药剂学上可接受的载体,本发明的药剂学上可接受的载体包括但不限于:
稀释剂:淀粉、糖粉、乳糖、糊精、微晶纤维素、无机盐、糖醇类等。
润湿剂与粘合剂:纯化水、乙醇、明胶、聚乙二醇、纤维素衍生物等。
崩解剂:淀粉、羧甲基淀粉钠、纤维素衍生物、交联聚维酮等。
润滑剂:硬脂酸镁、微粉硅胶、滑石粉、聚乙二醇等。
助溶剂:水、乙醇、甘油、丙二醇、液状石蜡、植物油等。
矫味剂:蔗糖、单糖、芳香剂等。
防腐剂:苯甲酸、山梨酸、甲酯、乙酯、丙酯等。
根据需要,制剂过程中还可以加入其它适宜的辅料,这些辅料的应用是制剂领域所公知的。根据实际制剂的需要,本领域技术人员可以从现有制剂辅料中进行筛选。
本发明的中药组合物可以通过下列方法制备:将药材洗净、烘干后,研磨成细粉混合均匀,加入适当的药用辅料制备成片剂、胶囊、丸剂、颗粒剂等药学可接受的任何药剂类型。
本发明还提供了前面所述的中药组合物的制备方法,该制备方法包括如下步骤:将中药原料洗净、烘干、粉碎后加水、乙醇等常用提取溶剂提取数次,合并提取液,过滤,将滤液浓缩成膏。而后将膏干燥、粉碎然后加入适当的药用辅料备成片剂、胶囊、药丸、冲剂等药学可接受的任何药剂类型。
作为可替换的技术方案,所述制备方法包括如下步骤:将部分中药原料洗净、烘干、粉碎后加水、乙醇等常用提取溶剂提取数次,合并提取液,过滤,将滤液浓缩成膏。而后将膏干燥、粉碎。其余部分中药原料采用研磨粉碎与膏粉混合然后加入适当的药用辅料备成片剂、胶囊、药丸、冲剂等药学可接受的任何药剂类型。
本发明的中药组合物还可以用中药领域最常规的水煮或水煮后醇沉的方法进行制备。
本发明的中药组合物还可以采用如下的制备方法:将中药原料洗净、烘干后,研磨成细粉混合均匀。
本发明提供了前面所述的中药组合物在制备治疗儿童重症肌无力的药物中的应用。
本发明提供了前面所述的药物制剂在制备治疗儿童重症肌无力的药物中的应用。
本发明的优点和有益效果如下:
本发明的中药组合物来源丰富,天然,制备工艺简单、制作费用低、疗效好、安全无副作用,适于在临床上推广使用。
具体实施方式
为了更好地理解和实施,下面结合实施例进一步说明本发明。如无特殊说明,本发明的实施例仅用于解释本发明,并不意味着限定本发明的保护范围。
本发明的中药组合物以及药物制剂在运用中医理论基础的前提下,经科学配方筛选,应用中药材采取科学提取工艺的前提下,精制加工而成。
实施例1中药组合物的制备
1、准确称量以下中药原料:黄芪10份、党参10份、白术10份、柴胡5份、升麻5份、当归5份、山萸肉5份、巴戟天5份、菟丝子5份、山药8份、制首乌6份、鸡血藤5份、枸杞5份、甘草3份、陈皮3份、麦冬3份。
2、将上述中药原料粉碎混合均匀。
实施例2中药组合物的制备
1、准确称量以下中药原料:黄芪120份、党参30份、白术20份、柴胡8份、升麻8份、当归10份、山萸肉10份、巴戟天10份、菟丝子10份、山药24份、制首乌30份、鸡血藤12份、枸杞12份、甘草6份、陈皮6份、麦冬10份。
2、将上述各中药原料用五倍量的水煎煮两次,每次两小时。滤过合并滤液,静置48小时后取其上清液减压浓缩成清膏后粉碎成细粉,或减压浓缩成稠膏。
实施例3中药组合物的制备
1、准确称量以下中药原料:黄芪60份、党参20份、白术15份、柴胡6份、升麻6份、当归7份、山萸肉7份、巴戟天7份、菟丝子7份、山药16份、制首乌18份、鸡血藤8份、枸杞8份、甘草5份、陈皮4份、麦冬6份。
2、将上述中药原料用三倍量的85%的乙醇回流三次,每次一小时。合并滤液,减压浓缩成清膏后粉碎成细粉,或减压浓缩成稠膏。
实施例4药物制剂的制备
1、口服液的制备
(1)按照实施例1-实施例3中的方法制备中药组合物清膏;
(2)加入20%苯甲酸乙醇溶液5ml和24%山梨酸钾溶液5ml,搅匀,冷藏48h以上,滤过,加水调整至每毫升含有生药5.5g,搅匀,灌封,即得口服液。
2、糖浆剂的制备
(1)按照实施例1-实施例3中的方法制备中药组合物清膏;
(2)加入辅料蔗糖、山梨酸、水搅拌均匀,制得糖浆剂。
3、片剂的制备
(1)按照实施例1-实施例3中的方法制备中药组合物清膏;
(2)加入辅料淀粉、乙醇、滑石粉,制得片剂。
4、胶囊剂的制备
(1)按照实施例1-实施例3中的方法制备中药组合物清膏;
(2)加入辅料淀粉、乙醇、糊精、硬脂酸镁,装入胶囊壳、制得胶囊剂。
5、颗粒剂的制备
(1)按照实施例1-实施例3中的方法制备中药组合物清膏;
(2)加入辅料糖粉、淀粉、糊精、乙醇,制得颗粒剂。
6、所述丸剂的制备方法包括以下步骤:
(1)按照实施例2-实施例3中的方法制备中药组合物稠膏;
(2)将膏状物团成丸状,即得。
7、所述合剂的制备方法包括以下步骤:
(1)按照实施例1-实施例3中的方法制备中药提取物稠膏;
(2)加入辅料蔗糖、乙酯、水、山梨酸搅拌均匀,制得合剂。
实施例5中药组合物的疗效
1、实验用药的制备
对比药物A制备:称取黄芪60份,党参20份,白术15份,茯苓10~30份,升麻10份,柴胡10份,枸杞子10份,当归10份,陈皮10份,炙甘草5份,菟丝子10份、薏苡仁10份、麦芽10份,淮山10份,山萸肉10份。用五倍量的水煎煮两次,每次两小时,滤过合并滤液,静置48小时后取其上清液减压浓缩成清膏;加入20%苯甲酸乙醇溶液5ml和24%山梨酸钾溶液5ml,搅匀,冷藏48h以上,滤过,加水调整至每毫升含有生药5.5g,搅匀,灌封,即得口服液。
对比药物B制备:称取黄芪120份,太子参20份,党参60份,白术20份,柴胡6份,升麻6份,当归7份,山药20份,合欢皮6份,制首乌18份,巴戟天7份,桑葚6份,甘草5份,陈皮4份,枳壳3份,鸡血藤20份,枸杞10份,麦冬6份。用五倍量的水煎煮两次,每次两小时,滤过合并滤液。静置48小时后取其上清液减压浓缩成清膏;加入20%苯甲酸乙醇溶液5ml和24%山梨酸钾溶液5ml,搅匀,冷藏48h以上,滤过,加水调整至每毫升含有生药5.5g,搅匀,灌封,即得口服液。
本发明的中药组合物制备:称取黄芪60份、党参20份、白术15份、柴胡6份、升麻6份、当归7份、山萸肉7份、巴戟天7份、菟丝子7份、山药16份、制首乌18份、鸡血藤8份、枸杞8份、甘草5份、陈皮4份、麦冬6份。用五倍量的水煎煮两次,每次两小时,滤过合并滤液,静置48小时后取其上清液减压浓缩成清膏;加入20%苯甲酸乙醇溶液5ml和24%山梨酸钾溶液5ml,搅匀,冷藏48h以上,滤过,加水调整至每毫升含有生药5.5g,搅匀,灌封,即得口服液。
2、试验人群:儿童患者人数为120人,随机分为3组,所有患者均经过下述诊断标准确诊为重症肌无力患者:
(1)新斯的明试验呈阳性:肌电图检查重复神经电刺激动作电位呈衰减。
(2)血清抗乙酰胆碱抗体阳性。
分别给予对比药物A、对比药物B、本发明的中药组合物,
剂量为每次150-200ml,日服用三次。连续服用一个月后观察治疗效果。
3、疗效评定标准:
治愈:临床症状和体征全部消失,,三个月无复发;
有效:临床症状和体征有所改善;
无效:临床症状和体征均无改善。
4、疗效结果
使用本发明的中药组合物的有效率达100%,效果好于对比药物A、对比药物B,具体数据参见表1所示。
表1 疗效结果统计
以上内容是结合具体的优选实施方式对本发明所作的进一步详细说明,不能认定本发明的具体实施只局限于这些说明。对于本发明所属技术领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干简单推演或替换,都应当视为属于本发明的保护范围。
Claims (10)
1.一种治疗儿童重症肌无力的中药组合物,其特征在于,所述中药组合物由以下重量份配比的中药原料制备而成:黄芪10-120份、党参10-30份、白术10-20份、柴胡5-8份、升麻5-8份、当归5-10份、山萸肉5-10份、巴戟天5-10份、菟丝子5-10份、山药8-24份、制首乌6-30份、鸡血藤5-12份、枸杞5-12份、甘草3-6份、陈皮3-6份、麦冬3-10份。
2.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物由以下重量份配比的中药原料配制而成:黄芪60份、党参20份、白术15份、柴胡6份、升麻6份、当归7份、山萸肉7份、巴戟天7份、菟丝子7份、山药16份、制首乌18份、鸡血藤8份、枸杞8份、甘草5份、陈皮4份、麦冬6份。
3.一种治疗儿童重症肌无力的药物制剂,其特征在于,所述药物制剂包括权利要求1或2所述的中药组合物。
4.根据权利要求3所述的药物制剂,其特征在于,所述药物制剂的剂型是药剂学上的常规口服剂型。
5.根据权利要求4所述的药物制剂,其特征在于,所述口服剂型是口服液、糖浆剂、颗粒剂、丸剂、片剂、胶囊、合剂。
6.权利要求1或2所述的中药组合物的制备方法,其特征在于,所述制备方法如下:将中药原料洗净、烘干后,研磨成细粉混合均匀。
7.权利要求1或2所述的中药组合物的制备方法,其特征在于,所述制备方法如下:将中药原料洗净、烘干、粉碎后提取数次,合并提取液,过滤,将滤液浓缩成膏,干燥后粉碎混合均匀。
8.权利要求1或2所述的中药组合物的制备方法,其特征在于,所述制备方法包括将中药原料水煮或水煮醇沉的步骤。
9.权利要求1或2所述的中药组合物在制备治疗儿童重症肌无力的药物中的应用。
10.权利要求3-5中任一项所述的药物制剂在制备治疗儿童重症肌无力的药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610129957.5A CN105535448B (zh) | 2016-03-07 | 2016-03-07 | 一种治疗儿童重症肌无力的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610129957.5A CN105535448B (zh) | 2016-03-07 | 2016-03-07 | 一种治疗儿童重症肌无力的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105535448A CN105535448A (zh) | 2016-05-04 |
CN105535448B true CN105535448B (zh) | 2020-09-29 |
Family
ID=55815356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610129957.5A Active CN105535448B (zh) | 2016-03-07 | 2016-03-07 | 一种治疗儿童重症肌无力的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105535448B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107115483B (zh) * | 2017-05-02 | 2020-09-29 | 马宇振 | 一种治疗肌营养不良、肌无力的药物组合物及其应用 |
CN108524775B (zh) * | 2018-07-13 | 2021-03-23 | 乞国艳 | 中药在制备治疗重症肌无力合并胸腺瘤的药物制剂中的应用 |
CN108653526B (zh) * | 2018-07-13 | 2021-03-16 | 乞国艳 | 中医治疗重症肌无力的药方 |
CN108524748B (zh) * | 2018-07-13 | 2021-05-14 | 乞国艳 | 治疗重症肌无力合并皮疹的中药组合物 |
CN111249437A (zh) * | 2020-04-20 | 2020-06-09 | 宋俊青 | 一种治疗重症肌无力的中药配方 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104069339A (zh) * | 2014-06-18 | 2014-10-01 | 乞国艳 | 一种治疗重症肌无力的中药组合物及其制备方法 |
-
2016
- 2016-03-07 CN CN201610129957.5A patent/CN105535448B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104069339A (zh) * | 2014-06-18 | 2014-10-01 | 乞国艳 | 一种治疗重症肌无力的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105535448A (zh) | 2016-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2016312007B2 (en) | Shenlingbaizhu granules and preparation method thereof | |
CN105535448B (zh) | 一种治疗儿童重症肌无力的中药组合物 | |
CN102416139B (zh) | 一种用于治疗乳腺疾病的中药组合物 | |
CN101837065B (zh) | 抗肝炎、抗肿瘤及提高机体免疫功能的药物及其制备方法 | |
AU2015345884B2 (en) | Drug or health care product preventing or treating liver and kidney damage-related diseases and use thereof | |
CN101933991B (zh) | 一种镇痛抗炎药物及其制备方法 | |
CN103230548B (zh) | 一种治疗肺心病的中药组合物 | |
CN102119970B (zh) | 一种用于治疗重症肌无力的中药组合物 | |
CN105012452A (zh) | 黄皮叶的新用途 | |
CN110507708B (zh) | 一种治疗乳腺增生的红花逍遥制剂及其制备方法和应用 | |
CN100371012C (zh) | 一种药物组合物及其制备方法和用途 | |
CN112206285A (zh) | 一种治疗心脑血管疾病的药物 | |
CN101199669A (zh) | 治疗男性精子质量低下的中药复方制剂 | |
CN110917311A (zh) | 一种用于保胎、调理经期及妇女更年期的中药口服液及其生产工艺 | |
CN1413697A (zh) | 中药六味地黄制剂的生产方法 | |
CN109876127B (zh) | 一种养血当归胶囊及其制备方法 | |
CN115040577A (zh) | 一种治疗萎缩性胃炎伴肠上皮化生及不典型增生的中药组合物及制备方法 | |
CN102058771A (zh) | 一种治疗失眠的中药制剂及其制备方法 | |
CN100428944C (zh) | 一种用于明目的中药复方制剂及其制备方法 | |
CN114366795A (zh) | 一种用于肠易激综合征的中药组合物、药物及制备方法和应用 | |
CN100998780B (zh) | 一种具有解表、去湿、和中的中药滴丸及其制备方法 | |
CN113101330B (zh) | 一种调经组合物及其应用 | |
CN1730081A (zh) | 治疗白内障眼疾的药物及制备方法 | |
CN109364213A (zh) | 一种治疗肝纤维化的复方中药 | |
CN108653526B (zh) | 中医治疗重症肌无力的药方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |